# Navinta, LLC – FDA Inspection, Sep 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/navinta-llc/89d9cbd4-879b-471f-8a04-efacf0821bff
Source feed: FDA_Inspections

> FDA inspection 1070302 of Navinta, LLC, September 18, 2018. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070302
- Company Name: Navinta, LLC
- Inspection Date: 2018-09-18
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 0

## Related Documents

- FDA Inspection 1252822 - 2024-09-30
- [FDA Inspection 1209856 - 2023-06-29](https://www.keypedia.com/records/fda_inspections/navinta-llc/a32b14ce-5c4a-4a08-acb7-8ebf80958519)
- FDA Inspection 1205480 - 2023-05-04
- [FDA Inspection 1084188 - 2019-03-28](https://www.keypedia.com/records/fda_inspections/navinta-llc/e5f0a259-43ef-4701-adfe-5b2f94d30760)
- [FDA Inspection 1022105 - 2017-08-18](https://www.keypedia.com/records/fda_inspections/navinta-llc/d7b6f6e5-255c-431f-99a7-3598a3c0f4ca)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)

Company: https://www.keypedia.com/companies/navinta-llc/2049d986-174a-414f-812b-0f4347426e48

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248